KR102499077B1 - Method for producing a wild ginseng cultured root extract and a cosmetic composition for wrinkle improvement using a ginsenoside complex obtained from a wild ginseng cultured root extract - Google Patents

Method for producing a wild ginseng cultured root extract and a cosmetic composition for wrinkle improvement using a ginsenoside complex obtained from a wild ginseng cultured root extract Download PDF

Info

Publication number
KR102499077B1
KR102499077B1 KR1020210117498A KR20210117498A KR102499077B1 KR 102499077 B1 KR102499077 B1 KR 102499077B1 KR 1020210117498 A KR1020210117498 A KR 1020210117498A KR 20210117498 A KR20210117498 A KR 20210117498A KR 102499077 B1 KR102499077 B1 KR 102499077B1
Authority
KR
South Korea
Prior art keywords
extract
wild ginseng
weight
ginsenoside
cultured
Prior art date
Application number
KR1020210117498A
Other languages
Korean (ko)
Other versions
KR20220122453A (en
Inventor
이유정
Original Assignee
주식회사 니코보코
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 니코보코 filed Critical 주식회사 니코보코
Priority to KR1020210117498A priority Critical patent/KR102499077B1/en
Publication of KR20220122453A publication Critical patent/KR20220122453A/en
Application granted granted Critical
Publication of KR102499077B1 publication Critical patent/KR102499077B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/645Proteins of vegetable origin; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60Sugars; Derivatives thereof
    • A61K8/602Glycosides, e.g. rutin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/68Sphingolipids, e.g. ceramides, cerebrosides, gangliosides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9706Algae
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52Stabilizers
    • A61K2800/524Preservatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59Mixtures
    • A61K2800/592Mixtures of compounds complementing their respective functions
    • A61K2800/5922At least two compounds being classified in the same subclass of A61K8/18

Abstract

이 발명은 미세조류 추출물에 함유된 복수의 펩타이드로부터 제조되는 펩타이드 복합물과, 특정 진세노사이드 함량이 증대된 산삼 배양근 추출물로부터 수득한 진세노사이드 복합물을 주성분으로 하여 보습, 미백 및 주름개선 효과를 나타낼 수 있는, 산삼배양근추출물 제조방법과 산삼배양근 추출물로부터 수득한 진세노사이드복합물을 이용한 주름개선용 화장료 조성물에 관한 것이다.The present invention is a peptide complex prepared from a plurality of peptides contained in a microalgae extract and a ginsenoside complex obtained from wild ginseng cultured root extract with increased specific ginsenoside content as main components to exhibit moisturizing, whitening and wrinkle improvement effects It relates to a method for producing cultured wild ginseng cultured root extract and a cosmetic composition for improving wrinkles using a ginsenoside complex obtained from cultured wild ginseng cultured root extract.

Description

산삼배양근추출물 제조방법과 산삼배양근 추출물로부터 수득한 진세노사이드복합물을 이용한 주름개선용 화장료 조성물{Method for producing a wild ginseng cultured root extract and a cosmetic composition for wrinkle improvement using a ginsenoside complex obtained from a wild ginseng cultured root extract}Method for producing a wild ginseng cultured root extract and a cosmetic composition for wrinkle improvement using a ginsenoside complex obtained from a wild ginseng cultured root extract}

이 발명은 미세조류 추출물에 함유된 복수의 펩타이드로부터 제조되는 펩타이드 복합물과, 특정 진세노사이드 함량이 증대된 산삼 배양근 추출물로부터 수득한 진세노사이드 복합물을 주성분으로 하여 보습, 미백 및 주름개선 효과를 나타낼 수 있는, 산삼배양근추출물 제조방법과 산삼배양근 추출물로부터 수득한 진세노사이드복합물을 이용한 주름개선용 화장료 조성물에 관한 것이다.The present invention is a peptide complex prepared from a plurality of peptides contained in a microalgae extract and a ginsenoside complex obtained from wild ginseng cultured root extract with increased specific ginsenoside content as main components to exhibit moisturizing, whitening and wrinkle improvement effects It relates to a method for producing cultured wild ginseng cultured root extract and a cosmetic composition for improving wrinkles using a ginsenoside complex obtained from cultured wild ginseng cultured root extract.

인간의 피부는 표피층, 진피층, 피부조직으로 구성되어있으며, 표피 아래의 진피층은 콜라겐과 엘라스틴, 히알루론산으로 구성되어 있다. 특히 콜라겐은 단백질의 일종인 아미노산으로 구성되는 결합조직으로, 인간의 노화가 진행되면서 치밀했던 콜라겐 섬유의 양이 줄고, 느슨해지면서 탄력이 떨어져 피부가 처지거나 팔자 주름이 깊게 패여 얼굴이 울퉁불퉁하고 넓어보이게 된다. 물론, 노화는 시간의 흐름에 따라 모든 인간들에게 공통적으로 나타나는 현상이지만 미(美)를 중시하는 많은 인간에게 노화란 재앙과도 같다.Human skin is composed of an epidermis layer, a dermis layer, and skin tissue, and the dermis layer below the epidermis is composed of collagen, elastin, and hyaluronic acid. In particular, collagen is a connective tissue composed of amino acids, a type of protein. As human aging progresses, the amount of dense collagen fibers decreases, and as they become loose, elasticity decreases, resulting in sagging skin or deep wrinkles on the face, making the face look rugged and wide. do. Of course, aging is a phenomenon common to all humans over time, but for many humans who value beauty, aging is like a disaster.

노화를 억제하기 위한 방법은 끊임없이 연구되고 있으며, 특히 상기의 콜라겐을 늘리는 방법 또한 함께 연구되고 있는 실정이다. 항노화 연구에서 주목받고 있는 성분 또한 다양하다. 특히 두 개 이상의 아미노산 결합으로 인하여 만들어진 물질인 펩타이드의 경우에도 진피층의 콜라겐을 직접적으로 보완할 수 있다는 점에서 주목받고 있는 성분이다. 펩타이드의 경우 단백질 형태보다 입자가 작아, 진피층에 깊숙이 침투된다는 장점이 있어 보다 나은 피부 개선 효과를 기대할 수 있다.Methods for suppressing aging are constantly being studied, and in particular, methods for increasing the collagen are also being studied together. There are also various ingredients that are attracting attention in anti-aging research. In particular, even in the case of peptides, which are substances made by combining two or more amino acids, they are attracting attention in that they can directly supplement collagen in the dermal layer. In the case of peptides, the particle size is smaller than that of protein, and it has the advantage of penetrating deeply into the dermal layer, so a better skin improvement effect can be expected.

참고로, 대한민국 공개특허공보 공개번호 10-2017-0003903의 경우 비타민과 펩타이드의 상호보완적 작용을 통하여 항노화 또는 주름개선 효과가 우수한 화장료 조성물을 제공하였다. 그러나 상기의 특허에 사용된 나이아신아마이드(비타민 B)의 경우 일정 성분 이상이 포함되었을 때, 조성물 내에서 석출되어 외용제의 안정성을 저하시킬 수 있으며, 아스코빌글루코사이드(비타민 C)의 경우 비타민 C 유도체로서 그 활성이 미약하다는 문제점이 존재하였다.For reference, in the case of Korean Patent Laid-open Publication No. 10-2017-0003903, a cosmetic composition with excellent anti-aging or anti-wrinkle effects was provided through complementary actions of vitamins and peptides. However, in the case of niacinamide (vitamin B) used in the above patent, when more than a certain component is included, it may precipitate in the composition and reduce the stability of external preparations, and in the case of ascorbyl glucoside (vitamin C) as a vitamin C derivative There was a problem that the activity was weak.

한국등록특허 제10-1803283호Korean Patent Registration No. 10-1803283

이 발명은 상기 문제점을 해결하기 위한 것으로, 미세조류로부터 수득된 각각의 펩타이드를 혼합하여 제조되는 펩타이드 복합물과, 특정 진세노사이드 함량이 증대된 산삼 배양근 추출물로부터 수득한 진세노사이드 복합물을 주 성분으로 하여 보습, 미백 및 주름개선 효과를 나타낼 수 있는, 산삼배양근추출물 제조방법과 산삼배양근 추출물로부터 수득한 진세노사이드복합물을 이용한 주름개선용 화장료 조성물을 제공하는 데 그 목적이 있다.The present invention is to solve the above problems, a peptide complex prepared by mixing each of the peptides obtained from microalgae, and a ginsenoside complex obtained from wild ginseng cultured root extract with increased specific ginsenoside content as main components The purpose is to provide a cosmetic composition for improving wrinkles using a method for preparing wild ginseng cultured root extract and a ginsenoside complex obtained from wild ginseng cultured root extract, which can exhibit moisturizing, whitening and wrinkle-improving effects.

상기 과제를 해결하기 위한 수단으로서, 이 발명의 구성은, 펩타이드 복합물 0.5~10.6 중량부, 정제수 40~90 중량부, 보습제 0.1~5 중량부, 세라마이드 0.001~10 중량부 및 보존제 0.01~2 중량부를 포함한다.As a means for solving the above problems, the configuration of the present invention comprises 0.5 to 10.6 parts by weight of the peptide complex, 40 to 90 parts by weight of purified water, 0.1 to 5 parts by weight of a moisturizer, 0.001 to 10 parts by weight of ceramide and 0.01 to 2 parts by weight of a preservative. include

상기 펩타이드 복합물은, The peptide complex,

클로렐라불가리스(Chlorella vulgaris) 추출물로부터 수득된 제1 펩타이드, 두나리엘라 살리나(Dunaliella salina) 추출물로부터 수득된 제2 펩타이드, 스키조키트리움 아그레가툼(Schizochytrium aggregatum) 추출물로부터 수득된 제3 펩타이드, 스키조키트리움 리마시눔(Schizochytrium limacinum) 추출물로부터 수득된 제4 펩타이드, 스키조키트리움 미너툼(Schizochytrium minutum) 추출물으로부터 수득된 제5 펩타이드, 크립테코디니움 코니(Crypthecodinium cohnii) 추출물로부터 수득된 제6 펩타이드 및 헤마토코쿠스 플루비알리스(Haematococus pluviallis) 추출물로부터 수득된 제7 펩타이드가 각각 1 : 2 : 2 : 1 : 1 : 2 : 2의 중량비율로 혼합된 것을 특징으로 하고,A first peptide obtained from a Chlorella vulgaris extract, a second peptide obtained from a Dunaliella salina extract, a third peptide obtained from a Schizochytrium aggregatum extract, Skizokit A fourth peptide obtained from a Schizochytrium limacinum extract, a fifth peptide obtained from a Schizochytrium minutum extract, a sixth peptide obtained from a Crypthecodinium cohnii extract, and Characterized in that the seventh peptide obtained from the Haematococus pluviallis extract was mixed in a weight ratio of 1: 2: 2: 1: 1: 2: 2,

상기 화장료 조성물은, 진세노사이드 복합물 0.001~15 중량부를 더 포함하고,The cosmetic composition further comprises 0.001 to 15 parts by weight of the ginsenoside complex,

상기 진세노사이드 복합물은, The ginsenoside complex,

산삼배양근으로부터 진세노사이드 Rg1 , Rg2를 각각 수득하고, 수득된 진세노사이드 Rg1 , Rg2를 각각 1~3 : 1~3의 중량비율로 혼합하여 이루어진 것을 특징으로 한다.Ginsenosides Rg1 and Rg2 are obtained from wild ginseng cultured roots, respectively, and the obtained ginsenosides Rg1 and Rg2 are mixed in a weight ratio of 1 to 3: 1 to 3, respectively.

상기 진세노사이드 복합물은, The ginsenoside complex,

산삼 배양근을 파쇄하여 온도 30℃, 습도 40% 조건으로 8시간 동안 1차 증자처리하고, 1차 증자처리된 산삼 배양근을 동결건조기에 넣고 -50℃에서 10시간 동안 1차 건조하고, 1차 건조된 산삼 배양근을 온도 30℃, 습도 40% 조건으로 8시간 동안 2차 증자처리하고, 2차 증자처리된 산삼 배양근을 동결건조기에 넣고 -50℃에서 10시간 동안 2차 건조한 후, 60 내지 120 메쉬 (mesh) 크기로 분쇄하여 산삼 배양근 분말을 제조하고,Wild ginseng cultured roots are crushed and subjected to primary steaming for 8 hours at a temperature of 30°C and humidity of 40%. The primary steamed cultured wild ginseng cultured roots are placed in a freeze dryer and first dried at -50°C for 10 hours, followed by primary drying. The cultured wild ginseng cultured roots were subjected to secondary steaming for 8 hours at a temperature of 30 ° C and humidity of 40%, and the secondary steamed cultured wild ginseng cultured roots were placed in a freeze dryer and dried a second time at -50 ° C for 10 hours, and then 60 to 120 mesh (mesh) to produce wild ginseng cultured root powder,

pH 4.8 구연산 수용액 100 중량부에 산삼 배양근 분말 1 중량부를 첨가하여 추출 혼합액을 제조하고, 추출 혼합액을 고압반응기에 8시간동안 투입한 후 추출 혼합액을 회수하고, 회수된 추출 혼합액으로부터 진세노사이드 Rg1 , Rg2를 각각 수득하여 혼합된 것을 특징으로 한다.An extraction mixture was prepared by adding 1 part by weight of wild ginseng cultured root powder to 100 parts by weight of an aqueous solution of pH 4.8 citric acid, and the extraction mixture was put into a high-pressure reactor for 8 hours, and then the extraction mixture was recovered. From the recovered extraction mixture, ginsenoside Rg1, It is characterized in that each of Rg2 is obtained and mixed.

이 발명은 미세조류 추출물에 함유된 복수의 펩타이드로부터 제조되는 펩타이드 복합물과, 특정 진세노사이드 함량이 증대된 산삼 배양근 추출물로부터 수득한 진세노사이드 복합물을 주성분으로 하여 노화방지, 보습, 미백 및 주름개선 효과를 나타낼 수 있다.The present invention is a peptide complex prepared from a plurality of peptides contained in a microalgae extract and a ginsenoside complex obtained from wild ginseng cultured root extract with increased specific ginsenoside content as main components to prevent aging, moisturize, whiten and improve wrinkles effect can be shown.

이하, 이 발명이 속하는 기술분야에서 통상의 지식을 가진 자가 이 발명을 용이하게 실시할 수 있을 정도로 상세히 설명하기 위하여, 이 발명의 바람직한 실시예를 첨부된 도면을 참조로 하여 상세히 설명하기로 한다. 이 발명의 목적, 작용, 효과를 포함하여 기타 다른 목적들, 그리고 동작상의 이점들이 바람직한 실시예의 설명에 의해 보다 명확해질 것이다.Hereinafter, preferred embodiments of the present invention will be described in detail with reference to the accompanying drawings in order to explain in detail enough that a person skilled in the art to which this invention pertains can easily practice this invention. Other objects and operational advantages, including the purpose, operation, and effect of this invention, will become clearer from the description of the preferred embodiments.

참고로, 여기에서 개시되는 실시예는 여러가지 실시가능한 예중에서 당업자의 이해를 돕기 위하여 가장 바람직한 실시예를 선정하여 제시한 것일 뿐, 이 발명의 기술적 사상이 반드시 제시된 실시예에만 의해서 한정되거나 제한되는 것은 아니고, 이 발명의 기술적 사상을 벗어나지 않는 범위내에서 균등물~대체물들을 포함하는 다양한 변화와 부가 및 변경이 가능하다.For reference, the embodiments disclosed herein are only presented by selecting the most preferred embodiments to help those skilled in the art to understand among various possible examples, and the technical spirit of the present invention is not necessarily limited or limited only by the presented embodiments. No, and various changes, additions, and changes including equivalents and substitutes are possible within the scope without departing from the technical spirit of the present invention.

또한, 명세서 및 청구범위에 사용된 용어나 단어의 표현은, 발명자가 자신의 발명을 가장 최선의 방법으로 설명하기 위해 용어의 개념을 적절하게 정의할 수 있다는 원칙에 입각하여 정의된 것으로서, 통상적이거나 사전적인 의미로만 한정해서 해석되어서는 아니되며, 이 발명의 기술적 사상에 부합하는 의미와 개념으로 해석되어야만 한다. 일예로서, 단수의 표현은 문맥상 명백하게 다르게 뜻하지 않는 한 복수의 표현을 포함한다.In addition, the terms or expressions of words used in the specification and claims are defined based on the principle that the inventor can appropriately define the concept of terms in order to best explain his or her invention. It should not be construed as limited only to the dictionary meaning, and should be interpreted as meaning and concept corresponding to the technical spirit of the present invention. As an example, singular expressions include plural expressions unless the context clearly dictates otherwise.

본 발명에 따른 미세조류 추출물로부터 수득한 펩타이드 복합물과 산삼 배양근 추출물로부터 수득한 진세노사이드 복합물을 포함하는 미백, 주름개선용 화장료 조성물은, 펩타이드 복합물 0.5~10.6 중량부, 진세노사이드 복합물 0.001~15 중량부, 정제수 40~90 중량부, 보습제 0.1~5 중량부, 세라마이드 0.001~10 중량부 및 보존제 0.01~2 중량부를 포함한다. A cosmetic composition for whitening and wrinkle improvement comprising a peptide complex obtained from a microalgae extract and a ginsenoside complex obtained from wild ginseng cultured root extract according to the present invention contains 0.5 to 10.6 parts by weight of the peptide complex and 0.001 to 15 parts by weight of the ginsenoside complex. parts by weight, 40 to 90 parts by weight of purified water, 0.1 to 5 parts by weight of a moisturizer, 0.001 to 10 parts by weight of ceramide, and 0.01 to 2 parts by weight of a preservative.

상기 펩타이드 복합물은, 클로렐라불가리스(Chlorella vulgaris) 추출물, 두나리엘라 살리나(Dunaliella salina) 추출물, 스키조키트리움 아그레가툼(Schizochytrium aggregatum) 추출물, 스키조키트리움 리마시눔(Schizochytrium limacinum) 추출물, 스키조키트리움 미너툼(Schizochytrium minutum) 추출물, 크립테코디니움 코니(Crypthecodinium cohnii) 추출물 및 헤마토코쿠스 플루비알리스(Haematococus pluviallis) 추출물로부터 수득된 각각의 펩타이드가 혼합된 펩타이드 복합물인 것을 특징으로 한다.The peptide complex is Chlorella vulgaris extract, Dunaliella salina extract, Schizochytrium aggregatum extract, Schizochytrium limacinum extract, Schizochytrium It is characterized in that each of the peptides obtained from Schizochytrium minutum extract, Crypthecodinium cohnii extract and Haematococus pluviallis extract is a mixed peptide complex.

스키조키트리움 아그레가툼 (Schizochytrium aggregatum), 스키조키트리움 리마시눔 (Schizochytrium limacinum) 및 스키조키트리움 미너툼 (Schizochytrium minutum)은 스키조키트리움 종(Schizochytrium sp.)으로 DNA 생산에 이용되고 있으며, 크립테코디니움 코니(Crypthecodinium cohnii) 역시 DNA 생산에 이용되고 있다.Schizochytrium aggregatum, Schizochytrium limacinum, and Schizochytrium minutum are Schizochytrium sp., used for DNA production, and Thecodinium cohnii (Crypthecodinium cohnii) is also used for DNA production.

헤마토코쿠스 플루비알리스(Haematococus pluviallis)는 헤마토코쿠스 종(Haematococus sp.)으로, 항산화성분인 아스타잔틴을 생산하는 것으로 알려져 있으며, 혈액순환 개선에 효능이 있는 것으로 알려져 있다.Haematococus pluviallis is a Haematococus sp., and is known to produce astaxanthin, an antioxidant, and is known to be effective in improving blood circulation.

이와 같은 7종의 미세조류들로부터 추출된 펩타이드는 신경세포에 작용하여 활성을 유도하고, 다양한 신호전달과정으로 피부 조직의 활성화를 유도하는 것으로 알려져 있다.Peptides extracted from these 7 types of microalgae are known to induce activity by acting on nerve cells and induce activation of skin tissue through various signal transduction processes.

진세노사이드(ginsenoside)란 글리코사이드(glycoside)의 일종인 사포닌의 한 종류로서, 식물의 뿌리, 줄기, 잎, 껍질, 씨 등에서 유래되며 일부의 극피동물(불가사리,해삼)의 몸안에도 포함되어 있다. 사포닌은 인체의 면역력을 높이는 성분으로 알려져있으며 특히 인삼, 홍삼, 산삼, 고삼, 흑삼등에 함유된 사포닌 종류인 진세노사이드가 유명하다. Ginsenoside is a type of saponin, a kind of glycoside. there is. Saponin is known as a component that enhances the body's immunity, and ginsenoside, a type of saponin contained in ginseng, red ginseng, wild ginseng, gosam, and black ginseng, is especially famous.

특히, 희귀진세노사이드는 인삼류에만 함유되어 있는 사포닌을 가리키는 단어로 다른 식물들의 사포닌과 구별하기 위해 사용되며, 진세노사이드들 중에서도 홍삼과 산삼에 주로 존재하는 진세노사이드를 말한다. 희귀 진세노사이드는 일반진세노사이드에 비해 물질의 사이즈가 작고 비교적 체내에 흡수되기 쉬운 구조적 특성을 가지고 있다. 그리고 일반 진세노사이드를 섭취하면 장내 미생물에 의해 희귀진세노사이드로 소량 전한되어 흡수되기는 하나, 개인별 차이가 크기 때문에 희귀진세노사이드 형태로 복용하는 것이 체내흡수율과 생체이용률 측면에서 더 효율적이라 할 수 있다.In particular, rare ginsenoside is a word that refers to saponin contained only in ginseng, and is used to distinguish it from saponin of other plants. Rare ginsenosides are smaller in size than general ginsenosides and have structural characteristics that are relatively easy to absorb into the body. In addition, when normal ginsenoside is ingested, a small amount is converted to rare ginsenoside by intestinal microorganisms and absorbed. However, since individual differences are large, taking it in the form of rare ginsenoside is more efficient in terms of absorption rate and bioavailability in the body. there is.

진세노사이드에는 진세노사이드 Rg1, Rg2, Rg3, Rg4. Rg6, Rb1, Rb2, Rh1, Rh2, Rc, Rd, Re, Ro 등의 다양한 종류가 존재하며, 식물의 종류와 재배조건, 추출방법, 인삼, 홍삼, 산삼의 부위 등에 따라 존재하는 진세노사이드의 종류 및 함량이 다르다.Ginsenosides include ginsenosides Rg1, Rg2, Rg3, Rg4. There are various types such as Rg6, Rb1, Rb2, Rh1, Rh2, Rc, Rd, Re, Ro, etc., and the amount of ginsenoside present depending on the type of plant, cultivation conditions, extraction method, and part of ginseng, red ginseng, and wild ginseng Different types and contents.

진세노사이드 Rg1은 면역기능 강화, 항피로 작용을 하는 물질로 알려져 있고, Rg2는 혈소판 응집 억제 작용을 하는 물질로 알려져 있다.Ginsenoside Rg1 is known as a substance that enhances immune function and acts as an anti-fatigue, and Rg2 is known as a substance that inhibits platelet aggregation.

본 발명에 따른 상기 진세노사이드 복합물은, 2회 증자처리 후 고압효소분해 과정을 거친 산삼배양근, 홍삼, 인삼, 흑삼 또는 고삼 중 어느 하나로부터 진세노사이드 Rg1 , Rg2를 각각 수득하고, 수득된 진세노사이드 Rg1 , Rg2를 각각 1~3 : 1~3의 중량비율로 혼합하여 이루어진 것을 특징으로 한다.The ginsenoside complex according to the present invention is obtained by obtaining ginsenosides Rg1 and Rg2 from any one of wild ginseng cultured roots, red ginseng, ginseng, black ginseng or high ginseng, which have been subjected to high-pressure enzyme degradation after two times of steaming, respectively, and the obtained ginseng It is characterized in that it is made by mixing senosides Rg1 and Rg2 in a weight ratio of 1 to 3: 1 to 3, respectively.

이하에서는 이러한 펩타이드 복합물 및 진세노사이드 복합물의 제조 방법에 대하여 설명하기로 한다.Hereinafter, methods for preparing the peptide complex and the ginsenoside complex will be described.

(펩타이드 복합물의 제조)(Preparation of peptide complex)

7종의 미세조류인 클로렐라불가리스(Chlorella vulgaris), 두나리엘라 살리나(Dunaliella salina), 스키조키트리움 아그레가툼(Schizochytrium aggregatum), 스키조키트리움 리마시눔(Schizochytrium limacinum), 스키조키트리움 미너툼(Schizochytrium minutum), 크립테코디니움 코니(Crypthecodinium cohnii) 및 헤마토코쿠스 플루비알리스(Haematococus pluviallis)를 각각의 생육 온도와 pH에 맞도록 배양조건과 배지를 준비하여 플라스크에서 10-30일간 계대 배양하였다.7 species of microalgae Chlorella vulgaris, Dunaliella salina, Schizochytrium aggregatum, Schizochytrium limacinum, Schizochytrium minantum ( Schizochytrium minutum), Crypthecodinium cohnii, and Haematococus pluviallis were subcultured in flasks for 10-30 days by preparing culture conditions and media suitable for each growth temperature and pH. did

배양용 인큐베이터에는 광합성이 원활히 일어나도록 광원을 설치하여 배양환경을 조성하고, 배양배지 내의 이산화탄소의 농도를 적정수준으로 유지하기 위하여 이산화탄소배양기를 이용하여 플라스크배양을 실시하였다.In the culture incubator, a light source was installed to facilitate photosynthesis to create a culture environment, and flask culture was performed using a carbon dioxide incubator to maintain the concentration of carbon dioxide in the culture medium at an appropriate level.

이후, 배양이 끝난 미세조류를 5,000~10,000rpm으로 20~30분간 각각 원심 분리하여 수분을 1차로 제거한 후, 원심 분리기를 통해 어느 정도 수분이 제거된 미세조류를 동결건조하여 잔여 수분을 2차로 제거하였다.Thereafter, the cultured microalgae are centrifuged at 5,000 to 10,000 rpm for 20 to 30 minutes to first remove moisture, and then freeze-dry the microalgae from which moisture has been removed to some extent through a centrifugal separator to secondarily remove residual moisture. did

수분 제거가 완료된 각각의 미세조류를 메탄올, 에탄올, 이소프로판올, 부탄올, 에틸렌, 아세톤, 헥산, 에테르, 클로로포름, 에틸아세테이트, 부틸아세테이트, 디클로로메탄, N,N-디메틸포름아미드(DMF), 디메틸설폭사이드(DMSO), 1,3-부틸렌글리콜, 프로필렌글리콜 또는 이들의 혼합용매인 유기용매를 사용하며 생약의 유효 성분이 파괴되지 않거나 최소화된 조건에서 실온 또는 가온하여 추출할 수 있다. 추출하는 유기용매에 따라 약제의 유효성분의 추출정도와 손실정도가 차이가 날 수 있으므로, 알맞은 유기용매를 선택하여 사용하도록 한다. 또 여기에 특별히 언급되지 아니한 공지의 다양한 추출 방법, 예컨대, 물리적 방법, 열수 추출, 에탄올 추출법 등을 통해서도 얻어질 수 있다.Methanol, ethanol, isopropanol, butanol, ethylene, acetone, hexane, ether, chloroform, ethyl acetate, butyl acetate, dichloromethane, N,N-dimethylformamide (DMF), dimethyl sulfoxide (DMSO), 1,3-butylene glycol, propylene glycol, or a mixture of these organic solvents are used, and the active ingredients of herbal medicines can be extracted at room temperature or heated under conditions that are not destroyed or minimized. Depending on the organic solvent to be extracted, the degree of extraction and loss of the active ingredient of the drug may differ, so select and use an appropriate organic solvent. In addition, it can be obtained through various known extraction methods not specifically mentioned herein, such as physical methods, hot water extraction, ethanol extraction, and the like.

유기용매에 흡수된 펩타이드를 추출하기 위해 펩타이드 크기에 맞는 여과막을 가진 분리기에 투입하여 펩타이드만 수득하고, 각각의 미세조류 추출물들로부터 추출된 7개의 펩타이드를 혼합한 펩타이드 복합물을 제조하였다.In order to extract the peptide absorbed in the organic solvent, it was put into a separator having a filter membrane suitable for the size of the peptide to obtain only the peptide, and a peptide complex was prepared by mixing 7 peptides extracted from each microalgae extract.

구체적으로, 본 발명에 따른 펩타이드 복합물은, 클로렐라불가리스(Chlorella vulgaris) 추출물로부터 수득된 제1 펩타이드, 두나리엘라 살리나(Dunaliella salina) 추출물로부터 수득된 제2 펩타이드, 스키조키트리움 아그레가툼(Schizochytrium aggregatum) 추출물로부터 수득된 제3 펩타이드, 스키조키트리움 리마시눔(Schizochytrium limacinum) 추출물로부터 수득된 제4 펩타이드, 스키조키트리움 미너툼(Schizochytrium minutum) 추출물로부터 수득된 제5 펩타이드, 크립테코디니움 코니(Crypthecodinium cohnii) 추출물로부터 수득된 제6 펩타이드 및 헤마토코쿠스 플루비알리스(Haematococus pluviallis) 추출물로부터 수득된 제7 펩타이드가 각각 1 : 2 : 2 : 1 : 1 : 2 : 2의 중량비율로 교반기에 투입한 후, 500 내지 1000rpm으로 5시간 내지 8시간 교반하여 얻을 수 있다.Specifically, the peptide complex according to the present invention is a first peptide obtained from Chlorella vulgaris extract, a second peptide obtained from Dunaliella salina extract, Schizochytrium aggregatum ) The third peptide obtained from the extract, the fourth peptide obtained from the Schizochytrium limacinum extract, the fifth peptide obtained from the Schizochytrium minutum extract, Cryptecodinium cony ( The sixth peptide obtained from Crypthecodinium cohnii) extract and the seventh peptide obtained from Haematococus pluviallis extract were added to the stirrer at a weight ratio of 1: 2: 2: 1: 1: 2: 2, respectively. After adding, it can be obtained by stirring at 500 to 1000 rpm for 5 hours to 8 hours.

(진세노사이드 복합물의 제조)(Preparation of ginsenoside complex)

먼저, 산삼 배양근 5 ㎏를 파쇄하여 온도 30℃, 습도 40% 조건으로 8시간 동안 1차 증자처리하였다. 다음으로, 1차 증자처리된 산삼 배양근을 동결건조기에 넣고 -50℃에서 10시간 동안 1차 건조하였다. 이어서, 1차 건조된 산삼 배양근을 온도 30℃, 습도 40% 조건으로 8시간 동안 2차 증자처리하였다. 다음으로, 2차 증자처리된 산삼 배양근을 동결건조기에 넣고 -50℃에서 10시간 동안 2차 건조하였다. First, 5 kg of wild ginseng cultured roots were crushed and subjected to primary steaming for 8 hours at a temperature of 30 ° C and a humidity of 40%. Next, the firstly steamed wild ginseng cultured roots were put in a freeze dryer and first dried at -50 ° C for 10 hours. Subsequently, the firstly dried wild ginseng cultured root was subjected to a second steaming treatment for 8 hours at a temperature of 30 ° C and a humidity of 40%. Next, the wild ginseng cultured roots subjected to secondary steaming were placed in a freeze dryer and secondary drying was performed at -50 ° C for 10 hours.

동결건조기로 건조한 시료를 각각 60 내지 120 메쉬 (mesh) 크기로 분쇄하여 천연물 분말을 제조하였다. 또한, 추출용매로서 이용하기 위한 구연산 수용액은 0.2M 구연산 용액의 pH가 4.8이 될 때까지 증류수로 희석하여 제조하여 사용하였다. 그 다음, 상기 제조한 pH 4.8 구연산 수용액 100 중량부에 천연물 분말(산삼 배양근 분말) 1 중량부를 첨가하여 추출 혼합액(시료 30mg/구연산용액 30mL)을 제조하였다. 상기의 추출혼합액 30mL 기준으로 Novozymes사(Bagsvaerd, Denmark)의 Viscozyme (KTN02214) 또는 Pectinex Ultra SP-L(KRN05658), 또는 두 가지 효소의 혼합물 (Viscozyme + Pectinex) 50 내지 100μL를 추출혼합액에 첨가한다.A natural product powder was prepared by pulverizing each sample dried by a lyophilizer into a size of 60 to 120 mesh. In addition, an aqueous solution of citric acid for use as an extraction solvent was prepared by diluting with distilled water until the pH of a 0.2M citric acid solution reached 4.8. Then, 1 part by weight of natural product powder (cultured wild ginseng cultured root powder) was added to 100 parts by weight of the pH 4.8 citric acid aqueous solution prepared above to prepare an extraction mixture (sample 30mg/citric acid solution 30mL). Based on 30 mL of the above extraction mixture, 50 to 100 μL of Viscozyme (KTN02214) or Pectinex Ultra SP-L (KRN05658) from Novozymes (Bagsvaerd, Denmark), or a mixture of the two enzymes (Viscozyme + Pectinex) is added to the extraction mixture.

이렇게 제조한 추출용 혼합액을 초고압반응기 전용 플라스틱 용기인 Polypropylene bag(Nasco, WHIRL-PAK-4oz.)에 투여하여 공기의 기포가 없도록 밀봉해서 고압효소반응 처리를 위한 시료를 준비하였다. 상기 효소를 포함하는 추출혼합액이 담긴 고압반응기 전용용기를 고압반응기(Toyo Koatsu사, TFS-2L)에 넣고, 고압반응기의 처리조건을 압력 100MPa, 온도를 50℃, 고압처리시간을 8시간으로 설정하여 가동하였다. 8시간 후에 추출혼합액을 회수하고, 추출혼합액 30mL 기준으로 에탄올 45mL를 첨가한 시료를 준비하였다. 비교군은 대기압(0.1MPa) 하의 45℃ Water-bath에서 4시간 침지시켜 추출한 산삼배양근 추출용액으로 하였다. The prepared mixture for extraction was administered to a polypropylene bag (Nasco, WHIRL-PAK-4oz.), which is a plastic container for ultra-high pressure reactors, and sealed so that there were no air bubbles to prepare samples for high-pressure enzyme reaction treatment. The high-pressure reactor-only vessel containing the extraction mixture containing the enzyme was placed in a high-pressure reactor (Toyo Koatsu, TFS-2L), and the treatment conditions of the high-pressure reactor were set to a pressure of 100 MPa, a temperature of 50 ° C, and a high-pressure treatment time of 8 hours. and started operating. After 8 hours, the extraction mixture was recovered, and a sample was prepared by adding 45 mL of ethanol based on 30 mL of the extraction mixture. The comparative group was an extract solution of cultured wild ginseng cultured roots extracted by immersion in a water-bath at 45 ° C under atmospheric pressure (0.1 MPa) for 4 hours.

위와 같은 방법으로 제조된 효소 및 초고압처리된 시료인 실험군과, 대기압 처리한 시료인 비교군에 포함된 진세노사이드의 종류 및 함량을 검출하기 위해 아래와 같은 방법에 따라 각 시료의 지표성분을 분석하였다.In order to detect the type and content of ginsenoside included in the experimental group, which is the sample prepared by the above method and ultra-high pressure treated sample, and the comparative sample, which is sample treated at atmospheric pressure, the index component of each sample was analyzed according to the method below. .

분석 절차Analytical procedure

1. 시험용액의 조제1. Preparation of test solution

1) 시료 약 1 g를 정밀히 달아 250 mL 환류용 플라스크에 넣고 50% 메탄올 용액 50 mL을 가하여 70~80oC의 수욕조에서 1시간 동안 환류 추출한 후 냉각시키고 원심 분리하여 상징액을 취한다(상징액A).1) Precisely weigh about 1 g of the sample, put it in a 250 mL reflux flask, add 50 mL of 50% methanol solution, extract under reflux for 1 hour in a 70-80oC water bath, cool, and centrifuge to take the supernatant (supernatant liquid A) .

2) 잔류물에 다시 50% 메탄올 용액 50 mL을 가하여 70~80oC의 수욕조에서 1시간 동안 환류 추출한 후 냉각시키고 원심 분리하여 상징액을 취한다(상징액B).2) Add 50 mL of 50% methanol solution to the residue, extract under reflux for 1 hour in a 70-80oC water bath, cool, and centrifuge to obtain supernatant (supernatant B).

3) 상징액A와 상징액B를 한데 합쳐서 250 mL 농축플라스크에 넣고 60℃ 이하에서 감압 농축한다.3) Combine supernatant A and supernatant B, put them in a 250 mL concentrating flask, and concentrate under reduced pressure at 60℃ or lower.

4) 농축물을 물-아세토니트릴(80:20 V/V) 혼합용매 2 mL에 녹인 후 0.45μm 멤브레인 필터로 여과하여 HPLC 분석용 시험용액으로 사용한다.4) After dissolving the concentrate in 2 mL of a water-acetonitrile (80:20 V/V) mixed solvent, filter it through a 0.45 μm membrane filter and use it as a test solution for HPLC analysis.

2. HPLC 분석2. HPLC analysis

시험용액 20 μL과 표준용액 20 μL을 HPLC에 주입하고 하기 조건에 따라 분석하여 각각의 진세노사이드의 피크 면적을 얻는다.20 μL of the test solution and 20 μL of the standard solution were injected into HPLC and analyzed according to the following conditions to obtain the peak area of each ginsenoside.

1) 칼럼: ODS (4.6 mm × 250 mm) 또는 이와 동등 이상의 것1) Column: ODS (4.6 mm × 250 mm) or equivalent or higher

2) 검출기: UV (측정파장: 203 nm)2) Detector: UV (measurement wavelength: 203 nm)

3) 이동상: 물-아세토니트릴 혼합용매 (유량: 1.6 mL/분)3) Mobile phase: water-acetonitrile mixed solvent (flow rate: 1.6 mL/min)

Figure 112021102230195-pat00001
Figure 112021102230195-pat00001

3) 진세노사이드 함량 산출3) Calculation of ginsenoside content

시료에 함유되어 있는 각각의 진세노사이드의 양은 다음 식에 준하여 계산한다.The amount of each ginsenoside contained in the sample is calculated according to the following formula.

[수학식 1][Equation 1]

Y=S(a*b) / A*0.001Y=S(a*b) / A*0.001

여기서, Y는 진세노사이드 함량, S는 시험용액 중 개별 진세노사이드의 농도(μg/mL), a는 시험용액의 전량(mL), b는 희석배수, A는 시료 채취량(g)을 의미한다.Here, Y is the ginsenoside content, S is the concentration of individual ginsenosides in the test solution (μg/mL), a is the total amount of the test solution (mL), b is the dilution factor, and A is the sample amount (g) do.

이와 같은 방법으로 산출된, 효소처리 및 초고압 처리한 시료의 진세노사이드의 총 함량은 28.34mg/g으로 대기압 처리한 시료(비교군)의 진세노사이드 함량(23.15mg/g) 대비 22.4% 증가하였다The total content of ginsenosides in the sample treated with enzyme treatment and ultra-high pressure, calculated in this way, was 28.34mg/g, which was 22.4% higher than the content of ginsenoside (23.15mg/g) in the sample treated with atmospheric pressure (comparison group). did

상기와 같은 방법으로, 산삼 배양근으로부터 진세노사이드 Rg1, Rg2를 각각 수득한 후, 진세노사이드 Rg1, Rg2를 각각 1~3 : 1~3의 중량비율로 교반기에 투입하여 500 내지 1000rpm으로 5시간 내지 8시간 교반함으로써 진세노사이드 복합물을 제조하였다.In the same way as above, after obtaining ginsenosides Rg1 and Rg2 from wild ginseng cultured roots, respectively, ginsenosides Rg1 and Rg2 were added to a stirrer at a weight ratio of 1-3: 1-3, respectively, and stirred at 500 to 1000 rpm for 5 hours. A ginsenoside complex was prepared by stirring for 8 to 8 hours.

(펩타이드 복합물 및 진세노사이드 복합물을 포함하는 화장료 조성물의 제조)(Preparation of cosmetic composition containing peptide complex and ginsenoside complex)

펩타이드 복합물 0.5~10.6 중량부, 진세노사이드 복합물 0.001~15 중량부, 정제수 40~90 중량부, 보습제 0.1~5 중량부, 세라마이드 0.001~10 중량부 및 보존제 0.01~2 중량부를 혼합하여 실시예로 제조하였다.0.5 to 10.6 parts by weight of the peptide complex, 0.001 to 15 parts by weight of the ginsenoside complex, 40 to 90 parts by weight of purified water, 0.1 to 5 parts by weight of a moisturizer, 0.001 to 10 parts by weight of ceramide and 0.01 to 2 parts by weight of a preservative. manufactured.

이 발명의 조성물은 총 중량에 대하여 상기 펩타이드 복합물을 0.5~10.6 중량부의 양으로 함유하는 것이 바람직하다. 펩타이드 복합물의 함량이 0.5 중량부 미만이면 멜라닌 생성 역제 효과가 낮아지는 문제가 있고, 10.6 중량부를 초과하면 피부 안전성 또는 제형상의 문제가 발생할 수 있다.The composition of the present invention preferably contains the peptide complex in an amount of 0.5 to 10.6 parts by weight based on the total weight. If the content of the peptide complex is less than 0.5 parts by weight, there is a problem that the melanin production inhibitory effect is lowered, and if it exceeds 10.6 parts by weight, problems in skin safety or formulation may occur.

이 발명은, 총 중량에 대하여 상기 진세노사이드 복합물을 0.001~15 중량부의 양으로 함유하는 것이 바람직하다. 진세노사이드 복합물의 함량이 0.001 중량부 미만이면 상기 성분에 의한 효능, 효과가 미약하고, 15 중량부를 초과하면 피부 안전성 또는 제형상의 문제가 발생할 수 있다.In this invention, it is preferable to contain the ginsenoside complex in an amount of 0.001 to 15 parts by weight based on the total weight. If the content of the ginsenoside complex is less than 0.001 parts by weight, the efficacy and effect of the above components are insignificant, and if it exceeds 15 parts by weight, problems in skin safety or formulation may occur.

상기 세라마이드는 지질에 속하는 물질이며, 피부 각질이 포함하고 있는 유지 중에서 가장 중요한 성분이며, 외부 환경에 대항하는 작용을 하는 피부 보호막을 형성하는 데도 큰 역할을 한다고 하며, 피부 지질 장벽을 강화하는 기능도 있다고 알려져 있다.The ceramide is a substance belonging to lipids, and is the most important component among oils and fats contained in skin keratin, and is said to play a large role in forming a skin protective film that acts against the external environment, and also has a function of strengthening the skin lipid barrier. It is known that there is

한편, 본 발명의 미세조류 추출물 유래의 펩타이드 복합물을 함유하는 화장료 조성물은 그 제형에 있어서 특별히 한정되는 바가 없는데, 예를 들면, 토너, 로션, 화장수, 젤, 수용성리퀴드, 크림, 에센스, 미스트, 수중유(O/W)형 및 유중수(W/O)형 등의 제형을 가질 수 있다. 그리고, 각제형의 화장료 조성물에 있어서, 상기 미세조류 추출물 유래의 펩타이드 복합물 외의 다른 성분들은 기타 화장료의 제형 또는 사용목적 등에 따라 당업자가 어려움 없이 선정하여 배합할 수 있다.On the other hand, the cosmetic composition containing the peptide complex derived from the microalgae extract of the present invention is not particularly limited in its formulation, for example, toner, lotion, lotion, gel, water-soluble liquid, cream, essence, mist, water It may have formulations such as heavy oil (O/W) type and water-in-oil (W/O) type. And, in the cosmetic composition of each dosage form, other components other than the peptide complex derived from the microalgae extract can be selected and blended without difficulty by those skilled in the art according to the formulation or purpose of use of other cosmetics.

이 발명에 따른 펩타이드 복합물, 진세노사이드 복합물 및 기타 보조성분들을 사용하여 하기 표 1에 나타난 조성비로 화장료 조성물을 제조하였다.A cosmetic composition was prepared in the composition ratio shown in Table 1 below using the peptide complex, ginsenoside complex and other auxiliary ingredients according to the present invention.

Figure 112021102230195-pat00002
Figure 112021102230195-pat00002

(실험예 1) 피부 개선 효과(Experimental Example 1) Skin improvement effect

이 발명에 따른 화장료 조성물의 피부 개선 효과를 확인하기 위하여 화장료 조성물(실시예 1~4, 비교예 1~4)을 준비하고, 20~50대 피험자 총 22명을 대상으로 피부 개선 평가실험을 수행하였다. 피험자는 8개의 그룹(실시예 1~4, 비교예 1~4)으로 나누었으며, 1일 1회씩 8주 동안 사용하도록 하였다. In order to confirm the skin improvement effect of the cosmetic composition according to the present invention, a cosmetic composition (Examples 1 to 4, Comparative Examples 1 to 4) was prepared, and a skin improvement evaluation experiment was conducted on a total of 22 subjects in their 20s to 50s. did The subjects were divided into 8 groups (Examples 1 to 4, Comparative Examples 1 to 4), and used once a day for 8 weeks.

먼저, 보습효과는 Tewameter를 이용하여 피부로부터 발산하는 수분량을 산정하여 Adolf Fick's Law에 따라 계산하였다. 화장료 조성물을 사용하기 전후 변화량을 수치화하였다.First, the moisturizing effect was calculated according to Adolf Fick's Law by calculating the amount of moisture emitted from the skin using a Tewameter. The amount of change before and after using the cosmetic composition was quantified.

다음으로, 미백 및 주름 개선 효과는 피험자의 의견에 따라 개선 정도를 점수로 기재하도록 하여 평가하였다.Next, the whitening and anti-wrinkle effect was evaluated by having the subject describe the degree of improvement as a score according to the opinion of the subject.

이어서, 멜라닌 생성 억제 효과는 피부 멜라노사이트에서 잘라틴 펩티드화합물의 멜라닌 생합성 측정 실험을 통해 확인하였다.Subsequently, the melanin production inhibitory effect was confirmed through an experiment measuring melanin biosynthesis of the zalatin peptide compound in skin melanocytes.

절단된 피부조직에 항생제(50mg/ml gentamicin, 50mg/ml amphotericin, 50U/ml penicillin, 50㎍/streptomycin)를 함유하는 인산완충용액 (PhosphateBufferedSaline)으로 세척하고 0.25% Trypsin/EDTA를 5분동안 처리하여 멜라노사이트 선택배지인 M2 배지 (Promocell)에서 5% CO2 및 37℃ 조건의 배양기에서 15일 동안 배양한 후에, 멜라노사이트 세포를 다시 0.25% Trypsin/EDTA로 떼어내어 혈구계수기로 세포수를 세어 M2 배지(Promocell)가 들어 있는 24-well 에 well당1× 104개로 접종한후 37℃에서 포가 well 닥에 80%d 이상 부착될 때까지 배양한다. 1일 배양후 멜라닌 색소의 전구체인 도파를 0.08mM 되게 첨가한 다음 젤라틴 펩티드화합물을 각각 0.5 중량%의 시험 농도로 첨가하고 3일 동안 배양하여 대조군에는 식염수를 넣었다. 배지를 제거한 세포를 인산완충용액(PBS, PhosphateBufferedSaline)세척하고, 이것을 트립신으로 처리하여 세포를 회수한다. 회수된세포는 헤마토사이토메터(Hematocytometer)를 이용하여 세포수를 측정한 후 5,000내지 10,000으로 10분간 원심분리한 다음 상등액을 제거하여 침전물을 얻는다.이 세포침전물은 60℃에서 건조한 후 10%가 함유된 1M 수산화나트륨액 100㎕를 넣어 60℃ 항온조에서 세포내 멜라닌을 얻는다. 이 액을 가지고 마이크로프레이트(Microplate)로 490 에서흡광도를 측정하여 세포수당 멜라닌함량을 젤라틴 펩티드화합물을 처리하지 않은 대조군과 실험군을 비교하여 %로 표시하였다. 그 결과를 하기 표 2에 나타내었다.The cut skin tissue was washed with phosphate buffered saline containing antibiotics (50mg/ml gentamicin, 50mg/ml amphotericin, 50U/ml penicillin, 50μg/streptomycin) and treated with 0.25% Trypsin/EDTA for 5 minutes. After culturing for 15 days in M2 medium (Promocell), a melanocyte selective medium, in an incubator under 5% CO 2 and 37 ° C conditions, melanocyte cells were detached with 0.25% Trypsin/EDTA and counted using a hemocytometer to obtain M2 After inoculating 1×10 4 per well in 24-well containing medium (Promocell), incubate at 37℃ until more than 80%d of cells are attached to the well dock. After culturing for 1 day, dopa, a precursor of melanin pigment, was added to 0.08 mM, and then gelatin peptide compounds were added at a test concentration of 0.5% by weight, respectively, and cultured for 3 days, and saline was added to the control group. The cells from which the medium was removed were washed with phosphate buffered saline (PBS), and treated with trypsin to recover the cells. The recovered cells are counted using a hematocytometer, centrifuged at 5,000 to 10,000 for 10 minutes, and then the supernatant is removed to obtain a precipitate. This cell precipitate is dried at 60°C and 10% Intracellular melanin was obtained by adding 100 μl of 1M sodium hydroxide solution containing the mixture in a thermostat at 60°C. The absorbance was measured at 490 using a microplate with this solution, and the melanin content per cell was compared between the control group and the experimental group not treated with the gelatin peptide compound and expressed as %. The results are shown in Table 2 below.

Figure 112021102230195-pat00003
Figure 112021102230195-pat00003

+++: 매우 양호한 개선 효과가 있음+++: very good improvement effect

++: 상당한 개선 효과가 있음 ++: significant improvement

+: 약간의 개선 효과가 있음 +: slight improvement

±: 개선 효과는 없으나 악화되지도 않음 ±: no improvement, but no deterioration

-: 개선 효과가 없고 오히려 악화됨 -: No improvement effect, rather worsened

상기 결과와 같이, 실시예 1~4를 사용한 피험자의 경우 높은 수분 함유량을 통해 우수한 보습효과를 나타냈으며, 피부 개선도를 우수하다고 평가하였다. 비교예 1~3의 화장료 조성물을 사용한 피험자는 피부 개선정도를 확연하게 느끼지 못했다는 평가를 나타냈으며, 비교예 4의 경우 피부개선 정도가 실시예와 비슷한 수준으로 나타났다. As the above results, in the case of the subjects using Examples 1 to 4, an excellent moisturizing effect was exhibited through a high water content, and the degree of skin improvement was evaluated as excellent. Subjects who used the cosmetic compositions of Comparative Examples 1 to 3 showed an evaluation that they did not clearly feel the degree of skin improvement, and in the case of Comparative Example 4, the degree of skin improvement was similar to that of Example.

또한, 멜라닌 억제 효과 실험에서 펩타이드 복합물이 포함되지 않은 비교예 1 에서 유일하게 멜라닌 함량이 월등히 높게 나타났다. 특히, 펩타이드 복합물 및 진세노사이드 복합물이 각각 함유된 실시예 4의 경우 월등히 감소한 것으로 나타났으며, 이는 펩타이드 복합물 및 진세노사이드 복합물의 함량이 본 발명에 따른 바람직한 비율로 혼합된 경우 피부 흡수율을 증대한 것으로 판단된다. 따라서 이 발명의 화장료 조성물은 피부 개선 효과를 나타낸다.In addition, in the melanin inhibitory effect test, the melanin content was found to be significantly high only in Comparative Example 1, which did not contain the peptide complex. In particular, in the case of Example 4 containing the peptide complex and the ginsenoside complex, respectively, it was found to be significantly reduced, which increases the skin absorption rate when the contents of the peptide complex and the ginsenoside complex are mixed in a preferred ratio according to the present invention it is judged to have been Therefore, the cosmetic composition of the present invention exhibits a skin improving effect.

(미세조류 유래 펩타이드 복합물의 혼합비율에 따른 효능 비교)(Comparison of efficacy according to mixing ratio of microalgae-derived peptide complex)

본 발명에 따른 펩타이드 복합물의 피부개선 효과를 더욱 심층적으로 비교하기 위해 미세조류 유래 펩타이드 복합물의 혼합비율에 따른 효능을 비교하였다. 구체적으로, 본 발명에 따른 펩타이드 복합물은, 클로렐라불가리스(Chlorella vulgaris) 추출물로부터 수득된 제1 펩타이드, 두나리엘라 살리나(Dunaliella salina) 추출물로부터 수득된 제2 펩타이드, 스키조키트리움 아그레가툼(Schizochytrium aggregatum) 추출물로부터 수득된 제3 펩타이드, 스키조키트리움 리마시눔(Schizochytrium limacinum) 추출물로부터 수득된 제4 펩타이드, 스키조키트리움 미너툼(Schizochytrium minutum) 추출물로부터 수득된 제5 펩타이드, 크립테코디니움 코니(Crypthecodinium cohnii) 추출물로부터 수득된 제6 펩타이드 및 헤마토코쿠스 플루비알리스(Haematococus pluviallis) 추출물로부터 수득된 제7 펩타이드가 각각 1 : 2 : 2 : 1 : 1 : 2 : 2의 중량비율로 혼합된 화장료 조성물을 실시예로 제조하였고, 상기한 비율과 상이한 비율로 혼합된 펩타이드 복합물을 포함하는 화장료 조성물을 비교예(표 3 참조)들로 제조하였다.In order to more in-depth compare the skin improvement effect of the peptide complex according to the present invention, the efficacy according to the mixing ratio of the microalgae-derived peptide complex was compared. Specifically, the peptide complex according to the present invention is a first peptide obtained from Chlorella vulgaris extract, a second peptide obtained from Dunaliella salina extract, Schizochytrium aggregatum ) The third peptide obtained from the extract, the fourth peptide obtained from the Schizochytrium limacinum extract, the fifth peptide obtained from the Schizochytrium minutum extract, Cryptecodinium cony ( The sixth peptide obtained from Crypthecodinium cohnii) extract and the seventh peptide obtained from Haematococus pluviallis extract were mixed in a weight ratio of 1: 2: 2: 1: 1: 2: 2, respectively. Cosmetic compositions were prepared in Examples, and cosmetic compositions containing a peptide complex mixed in a ratio different from the above ratio were prepared in Comparative Examples (see Table 3).

Figure 112021102230195-pat00004
Figure 112021102230195-pat00004

이후, 20세 이상 50세 미만의 성인남녀 총 50명의 시험대상자를 대상으로 10명씩 다섯 그룹으로 나누어 각 화장료 조성물을 정해진 시험 부위에 2주간 사용하게 하여 피부개선 정도를 확인하였다. 그 결과를 하기 표 4에 나타내었다.Thereafter, a total of 50 adult male and female subjects aged 20 to 50 were divided into 5 groups of 10 subjects, and each cosmetic composition was used on the designated test site for 2 weeks to confirm the degree of skin improvement. The results are shown in Table 4 below.

Figure 112021102230195-pat00005
Figure 112021102230195-pat00005

+++: 매우 양호한 개선 효과가 있음+++: very good improvement effect

++: 상당한 개선 효과가 있음 ++: significant improvement

+: 약간의 개선 효과가 있음 +: slight improvement

±: 개선 효과는 없으나 악화되지도 않음 ±: no improvement, but no deterioration

-: 개선 효과가 없고 오히려 악화됨 -: No improvement effect, rather worsened

상기 결과와 같이, 비교예 1~4를 사용한 피험자는 피부개선 효과를 확연하게 느끼지 못했다는 평가를 나타냈으며, 실시예를 사용한 피험자는 대체로 피부개선 효과가 우수하다고 평가하였다. 따라서, 이 발명에 따른 화장료 조성물은 실시예에 따른 비율로 각각의 펩타이드가 혼합되었을 때 피부개선 효과가 우수함을 알 수 있다.As the above results, the subjects using Comparative Examples 1 to 4 showed evaluation that they did not clearly feel the skin improvement effect, and the subjects using Examples generally evaluated the skin improvement effect as excellent. Therefore, it can be seen that the cosmetic composition according to the present invention has an excellent skin improvement effect when each peptide is mixed in the ratio according to the embodiment.

(진세노사이드 복합물의 구성성분에 따른 멜라닌 생성 억제 효과 비교)(Comparison of melanin production inhibitory effect according to the components of the ginsenoside complex)

한편, 본 발명에 따른 진세노사이드 복합물의 피부개선 효과 개선 성능을 더욱 심층적으로 비교하기 위해, 본 발명에 따라 진세노사이드 Rg1, Rg2 가 각각 1 : 2의 중량비율로 혼합되어 이루어지는 복합물을 함유한 화장료 조성물을 실험예로 제조하였고, 진세노사이드 Rg1, Rg2가 1: 1 의 중량비율로 혼합되어 이루어지는 복합물을 함유한 화장료 조성물을 비교예 1로, 진세노사이드 Rg1, Rg2가 각각 1 :3 의 중량비율로 혼합되어 이루어지는 복합물을 함유한 화장료 조성물을 비교예 2로, 진세노사이드 Rg1, Rg2 가 각각 2 : 1 의 중량비율로 혼합되어 이루어지는 복합물을 함유한 화장료 조성물을 비교예 3으로, 진세노사이드 Rg1, Rg2 가 각각 3 : 1의 중량비율로 혼합된 복합물을 함유한 화장료 조성물을 비교예 4로, 일반 홍삼 추출물이 함유된 화장료 조성물을 비교예 5로 제조하였다. On the other hand, in order to compare the skin improvement effect improvement performance of the ginsenoside complex according to the present invention more in-depth, according to the present invention, ginsenosides Rg1 and Rg2 were mixed in a weight ratio of 1: 2, respectively. A cosmetic composition was prepared as an experimental example, and a cosmetic composition containing a composite in which ginsenosides Rg1 and Rg2 were mixed in a weight ratio of 1: 1 was prepared as Comparative Example 1, and ginsenosides Rg1 and Rg2 were mixed in a weight ratio of 1: 3, respectively. In Comparative Example 2, a cosmetic composition containing a composite obtained by mixing in a weight ratio, and in Comparative Example 3, a cosmetic composition containing a composite obtained by mixing ginsenosides Rg1 and Rg2 in a weight ratio of 2: 1, A cosmetic composition containing a compound in which sides Rg1 and Rg2 were mixed at a weight ratio of 3:1 was prepared in Comparative Example 4, and a cosmetic composition containing a common red ginseng extract was prepared in Comparative Example 5.

Figure 112021102230195-pat00006
Figure 112021102230195-pat00006

이후, B16 멜라노마 세포 배양을 통하여 멜라닌 생성 억제 기능을 세포 수준에서 검정하였다. B16 멜라노마 세포는 10% 소혈청을 함유한 DMEM(Dulbecco's modified Eagle's Medium)에서 5% CO2, 37 ℃의 조건에서 2일간 배양하여 1.0 X 108 세포/T25 프라스크가 될 때까지 배양하였다. 그 다음, 실시예 및 비교예 1-5에 따른 시료를 세포에 투여하여 5% CO2, 37 ℃에서 2일간 배양하였다.Thereafter, the melanin production inhibitory function was assayed at the cellular level by culturing B16 melanoma cells. B16 melanoma cells were cultured in Dulbecco's modified Eagle's Medium (DMEM) containing 10% bovine serum under 5% CO 2 and 37 °C for 2 days until the number of cells reached 1.0 X 10 8 cells/T25 flask. Then, samples according to Examples and Comparative Examples 1-5 were administered to the cells and cultured for 2 days at 5% CO 2 and 37 °C.

그 후 트립신을 첨가하여 세포들을 수거하여 세포의 흑화 정도를 관찰하였다. 멜라닌이 생성되어 배출된 T25 플라스크의 상층액을 취해 475 nm에서 흡광도를 측정하여 멜라닌을 정량하고, 세포수는 수거된 세포: tryphan blue = 1 : 9 의 비율로 혼합하여 현미경으로 관찰하여 살아있는 세포수를 세어 단위 세포당 생성된 멜라닌의 양을 정량하여 저해 효과를 나타낸다.Thereafter, trypsin was added to collect the cells, and the degree of darkening of the cells was observed. The supernatant of the T25 flask from which melanin was produced and discharged was taken and the absorbance was measured at 475 nm to quantify melanin. It counts and quantifies the amount of melanin produced per unit cell to show the inhibitory effect.

Figure 112021102230195-pat00007
Figure 112021102230195-pat00007

상기와 같이, 진세노사이드 Rg1, Rg2 가 함유된 실시예 및 비교예 1-4는 일반적인 홍삼 추출물만 함유된 비교예 5보다 멜라닌 생성 억제율이 높음을 알 수 있으며, 특히 진세노사이드 Rg1, Rg2 가 각각 1 : 2 의 중량비율로 혼합되어 이루어지는 실시예의 멜라닌 생성 억제율이 월등히 높은 것을 알 수 있다.As described above, it can be seen that Examples and Comparative Examples 1-4 containing ginsenosides Rg1 and Rg2 have a higher melanin production inhibition rate than Comparative Example 5 containing only general red ginseng extract. In particular, ginsenosides Rg1 and Rg2 are It can be seen that the melanin production inhibition rate of the example obtained by mixing each in a weight ratio of 1: 2 is significantly high.

따라서, 본 발명에 따른 미세조류 추출물로부터 수득한 펩타이드 복합물과 진세노사이드 Rg1, Rg2 가 각각 1~3 : 1~3 의 중량비율로 혼합된 특정 진세노사이드 복합물을 포함하는 미백, 주름개선용 화장료 조성물은 피부개선 효과가 우수함을 알 수 있다.Therefore, a cosmetic for whitening and wrinkle improvement comprising a specific ginsenoside complex in which the peptide complex obtained from the microalgae extract according to the present invention and ginsenosides Rg1 and Rg2 are mixed in a weight ratio of 1 to 3: 1 to 3, respectively It can be seen that the composition has an excellent skin improvement effect.

이상 본 발명의 실시예를 설명하였지만, 본 발명이 속하는 기술분야에서 통상의 지식을 가진 자는 본 발명이 그 기술적 사상이나 필수적인 특징을 변경하지 않고서 다른 구체적인 형태로 실시될 수 있다는 것을 이해할 수 있을 것이다. 그러므로 이상에서 기술한 실시예들은 모든 면에서 예시적인 것이며 한정적이 아닌 것으로 이해해야만 한다.Although the embodiments of the present invention have been described above, those skilled in the art will understand that the present invention can be implemented in other specific forms without changing the technical spirit or essential features. Therefore, the embodiments described above should be understood as illustrative in all respects and not limiting.

Claims (3)

펩타이드 복합물 0.5~10.6 중량부, 정제수 40~90 중량부, 보습제 0.1~5 중량부, 세라마이드 0.001~10 중량부, 보존제 0.01~2 중량부 및 진세노사이드 복합물 0.001~15 중량부를 포함하며,
상기 펩타이드 복합물은,
클로렐라불가리스(Chlorella vulgaris) 추출물로부터 수득된 제1 펩타이드, 두나리엘라 살리나(Dunaliella salina) 추출물로부터 수득된 제2 펩타이드, 스키조키트리움 아그레가툼(Schizochytrium aggregatum) 추출물로부터 수득된 제3 펩타이드, 스키조키트리움 리마시눔(Schizochytrium limacinum) 추출물로부터 수득된 제4 펩타이드, 스키조키트리움 미너툼(Schizochytrium minutum) 추출물으로부터 수득된 제5 펩타이드, 크립테코디니움 코니(Crypthecodinium cohnii) 추출물로부터 수득된 제6 펩타이드 및 헤마토코쿠스 플루비알리스(Haematococus pluviallis) 추출물로부터 수득된 제7 펩타이드가 각각 1 : 2 : 2 : 1 : 1 : 2 : 2의 중량비율로 혼합된 것을 특징으로 하고,
상기 진세노사이드 복합물은,
산삼배양근으로부터 진세노사이드 Rg1 , Rg2를 각각 수득하고, 수득된 진세노사이드 Rg1 , Rg2를 각각 1~3 : 1~3의 중량비율로 혼합하여 이루어진 것을 특징으로 하는, 산삼배양근추출물 제조방법과 산삼배양근 추출물로부터 수득한 진세노사이드복합물을 이용한 주름개선용 화장료 조성물.
0.5 to 10.6 parts by weight of peptide complex, 40 to 90 parts by weight of purified water, 0.1 to 5 parts by weight of moisturizer, 0.001 to 10 parts by weight of ceramide, 0.01 to 2 parts by weight of preservative, and 0.001 to 15 parts by weight of ginsenoside complex,
The peptide complex,
A first peptide obtained from a Chlorella vulgaris extract, a second peptide obtained from a Dunaliella salina extract, a third peptide obtained from a Schizochytrium aggregatum extract, Skizokit A fourth peptide obtained from a Schizochytrium limacinum extract, a fifth peptide obtained from a Schizochytrium minutum extract, a sixth peptide obtained from a Crypthecodinium cohnii extract, and Characterized in that the seventh peptide obtained from the Haematococus pluviallis extract was mixed in a weight ratio of 1: 2: 2: 1: 1: 2: 2,
The ginsenoside complex,
Ginsenosides Rg1 and Rg2 are obtained from cultured wild ginseng roots, respectively, and the obtained ginsenosides Rg1 and Rg2 are mixed in a weight ratio of 1 to 3: 1 to 3, respectively. Cosmetic composition for wrinkle improvement using ginsenoside complex obtained from cultured root extract.
삭제delete 제1항에 있어서,
상기 진세노사이드 복합물은,
산삼 배양근을 파쇄하여 온도 30℃, 습도 40% 조건으로 8시간 동안 1차 증자처리하고, 1차 증자처리된 산삼 배양근을 동결건조기에 넣고 -50℃에서 10시간 동안 1차 건조하고, 1차 건조된 산삼 배양근을 온도 30℃, 습도 40% 조건으로 8시간 동안 2차 증자처리하고, 2차 증자처리된 산삼 배양근을 동결건조기에 넣고 -50℃에서 10시간 동안 2차 건조한 후, 60 내지 120 메쉬 (mesh) 크기로 분쇄하여 산삼 배양근 분말을 제조하고,
pH 4.8 구연산 수용액 100 중량부에 산삼 배양근 분말 1 중량부를 첨가하여 추출 혼합액을 제조하고, 추출 혼합액을 고압반응기에 8시간동안 투입한 후 추출 혼합액을 회수하고, 회수된 추출 혼합액으로부터 진세노사이드 Rg1 , Rg2를 각각 수득하여 혼합된 것을 특징으로 하는, 산삼배양근추출물 제조방법과 산삼배양근 추출물로부터 수득한 진세노사이드복합물을 이용한 주름개선용 화장료 조성물.
According to claim 1,
The ginsenoside complex,
Wild ginseng cultured roots are crushed and subjected to primary steaming for 8 hours at a temperature of 30°C and humidity of 40%. The primary steamed cultured wild ginseng cultured roots are placed in a freeze dryer and first dried at -50°C for 10 hours, followed by primary drying. The cultured wild ginseng cultured roots were subjected to secondary steaming for 8 hours at a temperature of 30 ° C and humidity of 40%, and the secondary steamed cultured wild ginseng cultured roots were placed in a freeze dryer and dried a second time at -50 ° C for 10 hours, and then 60 to 120 mesh (mesh) to produce wild ginseng cultured root powder,
An extraction mixture was prepared by adding 1 part by weight of wild ginseng cultured root powder to 100 parts by weight of an aqueous solution of pH 4.8 citric acid, and the extraction mixture was put into a high-pressure reactor for 8 hours, and then the extraction mixture was recovered. From the recovered extraction mixture, ginsenoside Rg1, A cosmetic composition for improving wrinkles using a method for preparing wild ginseng cultured root extract and a ginsenoside complex obtained from wild ginseng cultured root extract, characterized in that Rg2 is obtained and mixed.
KR1020210117498A 2021-02-26 2021-09-03 Method for producing a wild ginseng cultured root extract and a cosmetic composition for wrinkle improvement using a ginsenoside complex obtained from a wild ginseng cultured root extract KR102499077B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020210117498A KR102499077B1 (en) 2021-02-26 2021-09-03 Method for producing a wild ginseng cultured root extract and a cosmetic composition for wrinkle improvement using a ginsenoside complex obtained from a wild ginseng cultured root extract

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020210026976A KR102301576B1 (en) 2021-02-26 2021-02-26 Cosmetic composition for whitening and wrinkle improvement, comprising a peptide complex obtained from microalgae extract and a ginsenoside complex obtained from a wild ginseng cultured root extract
KR1020210117498A KR102499077B1 (en) 2021-02-26 2021-09-03 Method for producing a wild ginseng cultured root extract and a cosmetic composition for wrinkle improvement using a ginsenoside complex obtained from a wild ginseng cultured root extract

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
KR1020210026976A Division KR102301576B1 (en) 2021-02-26 2021-02-26 Cosmetic composition for whitening and wrinkle improvement, comprising a peptide complex obtained from microalgae extract and a ginsenoside complex obtained from a wild ginseng cultured root extract

Publications (2)

Publication Number Publication Date
KR20220122453A KR20220122453A (en) 2022-09-02
KR102499077B1 true KR102499077B1 (en) 2023-02-13

Family

ID=77777197

Family Applications (3)

Application Number Title Priority Date Filing Date
KR1020210026976A KR102301576B1 (en) 2021-02-26 2021-02-26 Cosmetic composition for whitening and wrinkle improvement, comprising a peptide complex obtained from microalgae extract and a ginsenoside complex obtained from a wild ginseng cultured root extract
KR1020210117498A KR102499077B1 (en) 2021-02-26 2021-09-03 Method for producing a wild ginseng cultured root extract and a cosmetic composition for wrinkle improvement using a ginsenoside complex obtained from a wild ginseng cultured root extract
KR1020210117463A KR102499073B1 (en) 2021-02-26 2021-09-03 Method for manufacturing microalgae extract and cosmetic composition for wrinkle improvement using peptide complex obtained from microalgae extract

Family Applications Before (1)

Application Number Title Priority Date Filing Date
KR1020210026976A KR102301576B1 (en) 2021-02-26 2021-02-26 Cosmetic composition for whitening and wrinkle improvement, comprising a peptide complex obtained from microalgae extract and a ginsenoside complex obtained from a wild ginseng cultured root extract

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1020210117463A KR102499073B1 (en) 2021-02-26 2021-09-03 Method for manufacturing microalgae extract and cosmetic composition for wrinkle improvement using peptide complex obtained from microalgae extract

Country Status (1)

Country Link
KR (3) KR102301576B1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20230157777A (en) * 2022-05-10 2023-11-17 주식회사 엘지생활건강 Novel Chlorella vulgaris strain and use thereof
KR20240032203A (en) 2022-08-30 2024-03-12 주식회사 바이오셀트란 Complex peptide for whitening and cosmetic composition containing same

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090281048A1 (en) 2008-05-07 2009-11-12 Pitcher Stephen N Method and System for Inducing Anti-aging in Skin
WO2013149323A1 (en) 2012-04-02 2013-10-10 Ntegrity Natural products for skin care
KR102009633B1 (en) 2019-02-18 2019-08-13 코스맥스 주식회사 Composition for improving skin beauty comprising extract of solid state fermented ginseng by Aspergillus cristatus strain

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20120041404A (en) * 2010-10-21 2012-05-02 (주)퓨어테크 피앤티 Cosmetic solution from algae peptide
KR102395982B1 (en) * 2015-01-09 2022-05-11 (주)아모레퍼시픽 Composition comprising ginseng extracts with enhanced ginsenoside content
KR20160101794A (en) * 2015-02-17 2016-08-26 이정순 A composition for antioxidating, whitening and improving wrinkle comprising extracts of wild ginseng culture roots treated with enzyme
KR20170016195A (en) * 2015-08-03 2017-02-13 김일광 Cosmetic composition for skin aging prevention, skin-whitening and antiwrinkle comprising low molecular ginsenoside and manufacture of the same
KR101814523B1 (en) * 2016-03-14 2018-01-04 농업회사법인 미션알지파워 주식회사 Functional cosmetic composition using microalgae extracts and method for manufacturing the same
KR101803283B1 (en) 2016-12-30 2017-12-01 (주)아모레퍼시픽 Anti-aging or anti-wrinkle cosmetic composition
JP2019151452A (en) * 2018-03-02 2019-09-12 日本電産株式会社 Management system of article
KR102255283B1 (en) * 2019-05-03 2021-05-24 주식회사 에이치비엘글로벌 Mask pack composition containing complex mixtures comprising the extraction mixture from marine plants and mask pack using the same

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090281048A1 (en) 2008-05-07 2009-11-12 Pitcher Stephen N Method and System for Inducing Anti-aging in Skin
WO2013149323A1 (en) 2012-04-02 2013-10-10 Ntegrity Natural products for skin care
KR102009633B1 (en) 2019-02-18 2019-08-13 코스맥스 주식회사 Composition for improving skin beauty comprising extract of solid state fermented ginseng by Aspergillus cristatus strain

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
JPWO2019151452 A1

Also Published As

Publication number Publication date
KR102499073B1 (en) 2023-02-13
KR20220122453A (en) 2022-09-02
KR20220122452A (en) 2022-09-02
KR102301576B1 (en) 2021-09-10

Similar Documents

Publication Publication Date Title
KR102499077B1 (en) Method for producing a wild ginseng cultured root extract and a cosmetic composition for wrinkle improvement using a ginsenoside complex obtained from a wild ginseng cultured root extract
US10675233B2 (en) Compositions containing natural extracts and use thereof for skin and hair
KR101825704B1 (en) A cosmetic composition comprising coffee silver skin extract
KR101308669B1 (en) Cosmetic composition with the nebaneba complex of hibiscus esculentus, laminaria japonica, dioscorea opposita, corchorus olitorius and nelumbo nucifera, polyglutamic acid
US20180280457A1 (en) Composition for preventing alopecia or stimulating hair growth containing extracellular polysaccharide produced from ceriporia lacerata as active ingredient
KR102009676B1 (en) Cosmetic Composition Comprising Bamboo Fermented Extract
JP2024009897A (en) Composition for promoting differentiation or proliferation of human adipose-derived stem cell
US11337916B2 (en) Myrciaria dubia fruit extracts rich in organic acids, cosmetic compositions comprising same and cosmetic uses thereof
JP4891274B2 (en) Biaryl compounds and cosmetics
KR101978850B1 (en) A functional cosmetic composition comprising high purity melittin, Ginsenoside Rb1, Rg3 and extracts from fruits of Rosa davurica pall and preparing method thereof
KR102617856B1 (en) A composition for anti-aging comprising mixture of snow lotus (Saussurea Involucrata), Usnea Barbata (Lichen) and Panax Ginseng Root extracts/ Bacillus ferment
KR20190049067A (en) A cosmetic composition comprising extract of coffee silver skin and coffee grounds
KR20140089305A (en) Composition for improving skin whitening or skin wrinkle comprising extracts of Quercus salicina Blume
KR20150058635A (en) Composition containing fermentated opuntia humifusa showing biological activity of skin
CN112638357B (en) Composition for promoting differentiation or proliferation of human fat-derived stem cells
CN113631227A (en) Antiaging agent, antioxidant, antiinflammatory agent, whitening agent, and cosmetic
KR20200084847A (en) A composition for promoting the differentiation of human adipose derived stem cell
KR20210094312A (en) Cosmetic composition for enhancing skin barrier function and manufacturing method thereof
KR102491017B1 (en) Composition for Anti-glycation, Anti-oxidation, Anti-Wrinkle, and Moisturizing Property Comprising Seaweed and Peptide as Active Ingredient
US10022317B2 (en) Composition comprising an extract of herbal medicine processed by an oriental herbal medicine processing
KR102006872B1 (en) Cosmetic Composition Comprising Fermented Oil Extract of Oriental Medicine Fruits
KR102311011B1 (en) A composition for promoting the proliferation of human adipose derived stem cell
KR102326086B1 (en) Composition for Improving Skin Conditions Having Skin Whitening, Moisturizing, Anti-Wrinkle and Skin Barrier Property Comprising Complex Extracts of Broussonetia kazinoki as Active Ingredient
KR102503007B1 (en) A composition for promoting the differentiation of human adipose derived stem cell
KR20180114336A (en) Cosmetic composition containing vaccinium vitis-idaea fruit extract fermented by aureobasidium pullulans

Legal Events

Date Code Title Description
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant